Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprotinin in Elective Primary Total Hip Replacement
NCT00668031Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2005
- Primary completion
- Jan 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial comparing Aprotinin Arm with Placebo Arm (2 arms). Primary endpoint: Percent of subjects requiring a blood transfusion. Started Feb 2005; status: completed.
02
Drugs
aprotinin
Beyond the preview
Go deeper on NCT00668031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00668031.